Maximizing the Impact of Medical Affairs in Oncology Product Launches: Timeline, Resources and Preparedness

As a key conduit between pharma organizations and key opinion leaders, Medical Affairs has become one of the key players in oncology product launches. In order to maximize oncology launch impact, Medical Affairs groups need to develop and maintain a strategic timeline for launch activities; deploy resources at appropriate points in this timeline; and ensure that launch preparedness metrics are used to ensure activities adhere to the timeline.

Best Practices, LLC undertook this benchmarking research to explore how Medical Affairs can maximize its oncology launch impact. This study provides insights and benchmarks around staffing, budgeting, timeline, preparedness metrics, tools and technology for an effective oncology launch. It also highlights the critical success factors and pitfalls for Medical Affairs during oncology launch.

KEY TOPICS

• Oncology launch timeline
• Oncology launch resourcing
• Oncology launch enablers

• Indicate the time when each Medical Affairs group ideally should get involved in oncology product launch activities and when each group actually becomes involved
• Indicate the total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for your product
• Indicate the percentage of total Medical Affairs launch budget allocated to each of the listed activities
• Indicate the percentage of total Medical Affairs staffing allocated to each of the listed activities
• Have you developed a launch dashboard to measure the value and impact of Medical Affairs role in oncology launch success and to monitor launch progress?
• In your experience, what have been the critical success factors that drive successful oncology launch for Medical Affairs?
• What are the major pitfalls for Medical Affairs during oncology product launch?

• Develop, deploy and stick to a launch timeline: Use launch roadmap to coordinate the Medical Affairs activities with other functions, understand interdependencies, and which activities to prioritize and where to allocate funding.
  • Develop timeline for critical launch activities around strategy, research, communications, data generation and other activities. Specify discrete and continuous activities.
  • Have a full Medical Affairs team 18-24 months before the launch, including securing the Medical Affairs field resources, leadership and project management milestones.
    

Best Practices, LLC engaged over 35 oncology Medical Affairs experts from 25 pharmaceutical and biotechnology companies in this research study through a benchmarking survey, interviews and a roundtable discussion.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.